Eric Topol· @EricTopol · X·· 3 小时前AI 评分28
AI 导读
据FDA，美国一家复方药房生产的GLP-1药物（替尔泊肽）因使患者面临风险而全国召回 https://www.usatoday.com/story/money/consumer-protection/recalls-alerts/2026/10/19/glp-1-injections-nationwide-recall/92332991007/
正文 · 原文
National recall of GLP-1 drug (tirzepatide) made by a US compounding pharmacy because it puts patients at risk, according to FDA
https://www.usatoday.com/story/money/consumer-protection/recalls-alerts/2026/10/19/glp-1-injections-nationwide-recall/92332991007/
来源：Eric Topol · x.com